Vor Biopharma (VOR) Jumps 10% on Addition of 2 CEOs to Board
We recently published These 10 Stocks are Winning Big. Vor Biopharma Inc. (NASDAQ:VOR) is one of the best-performing stocks on Monday.
Vor Biopharma Inc. (VOR)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Leucadia National Ian Cumming And Joseph Steinberg | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 38,974,101 | $0.00 | 38,974,101 | 2024-12-30 | Filing | |
| $18.00 | 130,970 | $2,357,460.00 | 1,825,326 | 2021-02-09 | Filing | |
| $18.00 | 2,848,596 | $51,274,728.00 | 8,297,265 | 2021-02-09 | Filing | |
| $18.00 | 444,444 | $7,999,992.00 | 1,858,470 | 2021-02-09 | Filing | |
| $18.00 | 111,111 | $1,999,998.00 | 4,833,959 | 2021-02-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $19.75 | 213 | $4,206.75 | 4,501,882 | 2026-07-16 | Filing | |
| $15.77 | 165,150 | $2,604,415.50 | 2,402,095 | 2026-04-22 | Filing | |
| $15.77 | 171,963 | $2,711,856.51 | 2,567,245 | 2026-04-20 | Filing | |
| $16.28 | 458,411 | $7,462,931.08 | 2,739,208 | 2026-04-17 | Filing | |
| $16.01 | 53,644 | $858,840.44 | 3,197,619 | 2026-04-15 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 979,890 | $18,701,443 | 0% | |
| 2. | 721,550 | $13,767,174 | 1.32% | |
| 3. | 97,557 | $1,861,388 | 0% | |
| 4. | 78,371 | $1,495,319 | 0.01% | |
| 5. | 53,732 | $1,025,207 | 0.13% |
News See All
10 Hot Penny Stocks to Invest in Now
In this article, we will look at the 10 Hot Penny Stocks to Invest in Now.
15 Pharmaceutical Stocks to Buy According to Peter Kolchinsky's RA Capital
In this piece, we will take a look at the top 15 pharmaceutical stocks to buy according to Peter Kolchinsky's RA Capital.
Hedge Fund Resource Center